Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Alejandro Majlis"'
Autor:
Pier Luigi Zinzani, Catherine Thieblemont, Vladimir Melnichenko, Krimo Bouabdallah, Jan Walewski, Alejandro Majlis, Laura Maria Fogliatto, Alejandro Martin Garcia-Sancho, Beth Christian, Zafer Gulbas, Muhit Özcan, Guilherme Fleury Perini, Herve Ghesquieres, Margaret A. Shipp, Seth Thompson, Samhita Chakraborty, Patricia Marinello, Philippe Armand
Publikováno v:
Blood Journal.
Previous analyses of the phase 2 KEYNOTE-170 (NCT02576990) study demonstrated effective antitumor activity and acceptable safety of pembrolizumab 200 mg given every 3 weeks for up to 35 cycles (~2 years) in patients with relapsed/refractory (R/R) pri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0e3dbcc07252f871f4e1fa0884c8e1e
https://doi.org/10.1182/blood.2022019340
https://doi.org/10.1182/blood.2022019340
Autor:
Gonzalo P. Méndez, Dorotea Fantl, Vivianne Lois, Natalia Schutz, Paola Mur, Camila Peña, Daniela Zamora, Christine Rojas, Verónica Verri, Hernán López-Vidal, Grupo de estudio latinoamericano de mieloma múltiple, Gonzalo Correa, Guillermo Andrés Duque Silva, Claudia Shanley, Jhoanna Ramirez, Gustavo Glavic, Paola Ochoa, Eloisa Riva, José Tomás Gonzalez, Ricardo Valjalo, Alejandro Majlis, Karen Jiset Saavedra Escobar
Publikováno v:
Nephrology. 25:442-449
Background Monoclonal gammopathy of renal significance (MGRS)-related lesions are infrequent entities. There are no publications on these disorders in Latin America (LA). The aim of this study was to describe epidemiological and clinical characterist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cd6dd39fd8d459ec99346b41cee21b2
https://doi.org/10.1111/nep.13685
https://doi.org/10.1111/nep.13685
Autor:
Miguel Cordova-Delgado, Mauricio P. Pinto, Carlos Regonesi, Luis Cereceda, José Miguel Reyes, Laura Itriago, Alejandro Majlis, Pablo Rodríguez, André Fassler, Mauricio Mahave, María Elisa León, Jorge Gallardo, María Paz Rodríguez Z., Alejandro Berkovits, Patricio Manque, Juvenal A. Ríos, Benjamín Garcia-Bloj, Marcelo Garrido
Publikováno v:
Journal of Personalized Medicine; Volume 12; Issue 2; Pages: 195
Major advances in sequencing technologies and targeted therapies have accelerated the incorporation of oncology into the era of precision medicine and “biomarker-driven” treatments. However, the impact of this approach on the everyday clinic has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1d03056f2684de635d22d01c160a531
https://pubmed.ncbi.nlm.nih.gov/35207683
https://pubmed.ncbi.nlm.nih.gov/35207683
Autor:
Seth Thompson, Philippe Armand, Muhit Ozcan, Patricia Marinello, Catherine Thieblemont, Pier Luigi Zinzani, Gilles Salles, Jan Waleswski, Margaret A. Shipp, Guilherme Fleury Perini, Laura Fogliatto, Alejandro Martin Garcia-Sancho, Krimo Bouabdallah, Zafer Gulbas, Vladimir Y. Melnichenko, Samhita Chakraborty, Alejandro Majlis, Beth Christian
Publikováno v:
Blood. 138:306-306
Introduction: Similar to classical Hodgkin lymphoma, primary mediastinal large B-cell lymphoma (PMBCL) expresses high level of the programmed cell death 1 (PD-1) ligands: PD-L1 and PD-L2. Prior analyses of the phase 2 KEYNOTE-170 (NCT02576990) study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89a2946d466f0b029c462bc1080248e8
https://doi.org/10.1182/blood-2021-148082
https://doi.org/10.1182/blood-2021-148082
Autor:
Maria T. Dibarrart, Alejandro Majlis, Alfonso T. Anguita-Compagnon, Daniel Araos, Laura Paredes, Marcela Vargas
Publikováno v:
Leukemialymphoma. 58(11)
Autologous stem cell transplantation (ASCT) is the standard of care for young patients with multiple myeloma (MM). Patients who are considered candidates for high-dose therapy typically receive 2–4...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d517c3653d216da14bea447d79b797e
https://pubmed.ncbi.nlm.nih.gov/28300458
https://pubmed.ncbi.nlm.nih.gov/28300458
Publikováno v:
Revista médica de Chile v.141 n.9 2013
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
El cancer de colon y recto es una importante causa de muerte en nuestro pais. El gen KRAS esta involucrado en la carcinogenesis entre 22-45% de los casos. El objetivo fue determinar la frecuencia y tipos de mutaciones del gen KRAS en el cancer de col
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42f7a055b9eafae67ca0c72f278ce5a2
https://doi.org/10.4067/s0034-98872013000900009
https://doi.org/10.4067/s0034-98872013000900009
Autor:
José Tomás Gonzalez, Gonzalo P. Méndez, Camila Peña, Alejandro Majlis, Ricardo Valjalo, Dorotea Fantl, Natalia Schutz, Daniela Zamora, Vivianne Lois, Hernán López-Vidal, Eloisa Riva
Publikováno v:
Blood. 132:5856-5856
Background Monoclonal gammopathy of renal significance (MGRS) is a recently defined entity. It is a group of renal diseases due to paraprotein deposition from a small B lymphocyte or plasma cell clon, not meeting the criteria for an overt gammopathy-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3165a64e8d3806c7c9120ee7c97529e5
https://doi.org/10.1182/blood-2018-99-113198
https://doi.org/10.1182/blood-2018-99-113198
Autor:
Lucile Awad, Sergei Tjulandin, Miguel Fodor, Eric Van Cutsem, Edouard Voznyi, Vladimir Moiseyenko, Manuel Constenla, Corrado Boni, Yee Chao, Jaffer A. Ajani, Alejandro Majlis, Adriano Rodrigues
Publikováno v:
Journal of Clinical Oncology. 25:3210-3216
Purpose Therapy of patients with advanced gastric or gastroesophageal junction cancer should provide symptom relief and improve quality of life (QOL) because most patients are symptomatic at baseline. Using validated instruments, we prospectively ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12091fe1f5747770adf3ac5e250faf22
https://doi.org/10.1200/jco.2006.08.3956
https://doi.org/10.1200/jco.2006.08.3956
Autor:
Manuel Constenla, Yee Chao, Vladimir M. Moiseyenko, Adriano Rodrigues, Corrado Boni, Alejandro Majlis, Sergei Tjulandin, Edouard Voznyi, Marie Laure Risse, Eric Van Cutsem, Miguel Fodor, Jaffer A. Ajani
Publikováno v:
Journal of Clinical Oncology. 24:4991-4997
Purpose In the randomized, multinational phase II/III trial (V325) of untreated advanced gastric cancer patients, the phase II part selected docetaxel, cisplatin, and fluorouracil (DCF) over docetaxel and cisplatin for comparison against cisplatin an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be68b0d551c71d94b029cbb99b8a33aa
https://doi.org/10.1200/jco.2006.06.8429
https://doi.org/10.1200/jco.2006.06.8429
Autor:
Yee Chao, Miguel B. Fodor, Eric Van Cutsem, Alejandro Majlis, Sergei A. Tjulandin, Vladimir M. Moiseyenko, Jaffer A. Ajani, Sebastiao Cabral Filho, Sylvie Assadourian
Publikováno v:
Journal of Clinical Oncology. 23:5660-5667
Purpose The purpose of this study was to define the contribution of docetaxel to combination chemotherapy in the outcome of patients with advanced gastric or gastroesophageal adenocarcinoma. We compared the overall response rate (ORR) and safety of d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5df5ba446bb31379ba082c07d72be939
https://doi.org/10.1200/jco.2005.17.376
https://doi.org/10.1200/jco.2005.17.376